Avecho Biotechnology Limited | ASX: AVE | ACN: 056 482 403 | ABN: 32 056 482 403 Unit 8A, 2A Westall Road, Hallmarc Business Park, Clayton VIC Australia 3168 avecho.com.au ASX Announcement 3 August 2026 Japanese patent...
Japanese patent granted for CBD capsule
Filed with ASX · · 3 pages · English
Release
Avecho Biotechnology Limited on 6ix
Story so far
Earlier from Avecho Biotechnology
- June 2026 Quarterly Activities Report & Appendix 4C
- Positive interim analysis advances Avecho Phase III insomnia program
- Positive interim results from Phase III insomnia program
- Receipt of Research & Development Tax Incentive
- Avecho completes treatment for Phase III interim analysis
Later from Avecho Biotechnology
- Small Holding Share Sale Facility Completion
- Avecho strengthens BD capability with senior appointment
- Appendix 4D and Half-year Financial Report
- Avecho enters final stage of Phase III insomnia trial
- Avecho to present at the ASX SMIDcaps Conference
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology